01Already in effect (changes were effective immediately): Providers and pharmacy staff should check the denosumab and ustekinumab tables in the notice against the preferred drug list, and update medication lists and formulary notes in the EHR so orders use the preferred biosimilars.
02Already effective November 1, 2026: For Medicare members, stop sending prior authorization requests for the codes the notice lists as removed on that date, including CPT 29848, 30520, 31256, 31267, 88271, 88275, 88280, 91110 through 91113, the DME and orthotic codes, and home health codes 99341 through 99350 and 99601 and 99602.
03Billing team: update the prior authorization tracker and front desk scheduling notes so these services are no longer held for a request.
04By January 1, 2027: Get prior authorization before scheduling wound care CPT 97605 and 97606 for Medicare members, and before scheduling scalp cooling CPT 97007, 97008 and 97009 for the plans shown as affected in the notice.
05Get authorization before administering the outpatient drugs listed as additions, including Yondelis (J9352), and check the notice's table for the plan columns that apply to each drug.
06Billing team: add the authorization number to the claim so it goes out complete.
07Also by January 1, 2027: remove prior authorization holds for CPT 21089, 40650, 40652 and 40654 for HMO members, and check provider update 26-989 for the Community Supports changes.
08Front desk and providers: verify member eligibility and benefits before providing services, because authorization does not confirm coverage.
09The notice says incomplete or incorrect requests may lead to member appeals or grievances, so submit complete requests on the first try.